Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients

Journal of General Virology

Volumn 87, Issue 10, 2006, Pages 2941-2949

  Toan, Nguyen L ^a,b   Duechting, Anja ^a   Kremsner, Peter G ^b,c   Song, Le H ^d   Ebinger, Martin ^b   Aberle, Susanne ^a   Binh, Vu O ^e   Duy, Dinh Ng ^d   Toressi, Joseph ^f   Kandolf, Reinhard ^a   Bock, C Thomas ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

^d Tran Hung Dao Hospital   (Viet Nam)

^e 354 Hospital   (Viet Nam)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; NUCLEOTIDE;

ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC CODE; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SUPERINFECTION; VIET NAM;

AMINO ACID SEQUENCE; BASE SEQUENCE; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHYLOGENY; VIETNAM;

HEPATITIS B VIRUS; PARVOVIRUS;

EID: 33749056595     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82037-0     Document Type: Article

References (40)

1. Anderson, M. J., Jones, S. E., Fisher-Hoch, S. P., Lewis, E., Hall, S. M., Bartlett, C. L. R., Cohen, B. J., Mortimer, P. P. & Pereira, M. S. (1983). Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet i, 1378.
2. Barah, F., Vallely, P. J., Chiswick, M. L., Cleator, G. M. & Kerr, J. R. (2001). Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 358, 729-730.
3. Bergoin, M. & Tijssen, P. (1998). Biological and molecular properties of densoviruses and their use in protein expression and biological control. In The Insect Viruses, pp. 141-169. Edited by L. K. Miller & L. A. Ball. New York: Plenum.
4. Bock, C.-T. (2006). Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy. Ernst Schering Res Found Workshop 55, 83-97.
5. Bock, C.-T., Klingel, K, Aberle, S., Duechting, A., Lupescu, A., Lang, F. & Kandolf, R. (2005). Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy. J Vet Med B Infect Dis Vet Public Health 52, 340-343.
6. Bültmann, B. D., Klingel, K., Sotlar, K., Bock, C. T., Baba, H. A., Sauter, M. & Kandolf, R. (2003). Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34, 92-95.
7. Candotti, D., Etiz, N., Parsyan, A. & Allain, J.-P. (2004). Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78, 12169-12178.
8. Cotmore, S. F., McKie, V. C., Anderson, L. J., Astell, C. R. & Tattersall, P. (1986). Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60, 548-557.
9. Dingli, D., Pfizenmaier, D. H., Arromdee, E., Wennberg, P. Spittell, P. C., Chang-Miller, A. & Clarke, B. L. (2000). Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356, 312-314.
10. Dorsch, S., Liebisch, G., Kaufmann, B., von Landenberg, P., Hoffmann, J. H., Drobnik, W. & Modrow, S. (2002). The VPI unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76, 2014-2018.
11. Erdman, D. D., Durigon, E. L., Wang, Q.-Y. & Anderson, L. J. (1996). Genetic diversity of human parvovirus B19: sequence analysis of the VP1/ VP2 gene from multiple isolates. J Gen Virol 77, 2767-2774.
12. Finkel, T. H., Török, T. J., Ferguson, P. J. & 8 other authors (1994). Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343, 1255-1258.
13. Fukada, K., Matumoto, K., Takakura, F., Yamaki, M., Sato, H., Okochi, K. & Maeda, Y. (2000). Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein. J Med Virol 62, 60-69.
14. Gallinella, G., Venturoli, S., Manaresi, E., Musiani, M. & Zerbini, M. (2003). B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 28, 1-13.
15. He, Z., Zhuang, H., Wang, X., Song, S., Dong, Q., Yan, J., Buehring, G. C. & Luo, G. (2003). Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection. J Med Virol 69, 59-65.
16. Heegaard, E. D. & Brown, K E. (2002). Human parvovirus B19. Clin Microbiol Rev 15, 485-505.
17. Hemauer, A., von Poblotzki, A., Gigler, A., Cassinotti, P., Siegl, G., Wolf, H. & Modrow, S. (1996). Sequence variability among different parvovirus B19 isolates. J Gen Virol 77, 1781-1785.
18. Hillingsøo, J. G., Jensen, I. P. & Tom-Petersen, L. (1998). Parvovirus B19 and acute hepatitis in adults. Lancet 351, 955-956.
19. Hokynar, K. M., Söderlund-Venermo, M., Pesonen, M., Ranki, A., Kiviluoto, O., Partio, E. K. & Hedman, K. (2002). A new parvovirus genotype persistent in human skin. Virology 302, 224-228.
20. Karetnyi, Y. V., Beck, P. R., Markin, R. S., Langnas, A. N. & Naides, S. J. (1999). Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144, 1713-1724.
21. Kimura, M. (1980). A simple method for estimating evolutionary rates of base substitutions through comparative studies of nudeotice sequences. J Mol Evol 16, 111-120.
22. Liefeldt, L., Plentz, A., Klempa, B., Kershaw, O., Endres, A.-S., Raab, U., Neumayer, H.-H., Meisel, H. & Modrow, S. (2005). Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75, 161-169.
23. Moore, T. L. (2000). Parvovirus-associated arthritis. Curr Opin Rheumatol 12, 289-294.
24. Morinet, F. (1992). Parvovirus B19 infection. Pathol Biol 40, 621-622 (in French).
25. Naides, S. J., Karetnyi, Y. V., Cooling, L. L. W. & 7 other authors (1996). Human parvovirus B19 infection and hepatitis. Lancet 347, 1563-1564.
26. Nguyen, Q. T., Wong, S., Heegaard, E. D. & Brown, K. E. (2002). Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301, 374-380.
27. Saitou, N. & Nei, M. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4, 406-425.
28. Sanabani, S., Neto, W. K., Pereira, J. & Sabino, E. C. (2006). Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 44, 604-606.
29. Servant, A., Laperche, S., Lallemand, F., Marinho, V., De Saint Maur, G., Meritet, J. F. & Garbarg-Chenon, A. (2002). Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76, 9124-9134.
30. Song, L. H., Binh, V. Q., Duy, D. N., Kun, J. F. J., Bock, C. T., Kremsner, P. G. & Luty, A. J. F. (2003). Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28, 93-103.
31. Song, L. H., Binh, V. Q., Duy, D. N., Bock, T. C., Kremsner, P. G., Luty, A. J. F. & Mavoungou, E. (2004). Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. J Med Virol 73, 244-249.
32. Sukhumsirichart, W., Attasart, P., Boonsaeng, V. & Panyim, S. (2006). Complete nucleotide sequence and genomic organization of hepatopancreatic parvovirus (HPV) of Penaeus monodon. Virology 346, 266-277.
33. Takahashi, Y., Murai, C., Shibata, S. & 7 other authors (1998). Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A 95, 8227-8232.
34. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
35. Toan, N. L., Song, L. H., Kremsner, P. G. & 7 other authors (2006). Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol (in press). doi:10.1016/ j.jhep.2006.03.013
36. Tschöpe, C., Bock, C.-T., Kasner, M. & 8 other authors (2005). High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111, 879-886.
37. Walker, S. L., Wonderling, R. S. & Owens, R. A. (1997). Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J Virol 71, 2722-2730.
38. Yoto, Y., Kudoh, T., Haseyama, K., Suzuki, N. & Chiba, S. (1996). Human parvovirus B19 infection associated with acute hepatitis. Lancet 347, 868-869.
39. Young, N. S. & Brown, K. E. (2004). Parvovirus B19. N Engl J Med 350, 586-597.
40. Zhi, N., Zádori, Z., Brown, K. E. & Tijssen, P. (2004). Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318, 142-152.